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Rondônia (UNIR), Porto Velho, RO, Brazil 
d Centro Para el Desarrollo de la Investigaci�on Científica (CEDIC), Asunci�on, Paraguay 
e Centro Universit�ario S~ao Lucas (UniSL), Porto Velho, RO, Brazil 
f Departamento de Física e Biofísica, Instituto de Biociências, S~ao Paulo State University, UNESP, Botucatu, SP, Brazil  
A B S T R A C T   
The complete knowledge of the toxins that make up venoms is the base for the treatment of snake accidents victims and the selection of specimens for the preparation 
of venom pools for antivenom production. In this work, we used a fast and direct venomics approach to identify the toxin families in the C.d. terrificus venom, a 
Southern American Neotropical rattlesnake. The RP-HPLC separation profile of pooled venom from adult specimens followed by mass spectrometry analysis revealed 
that C.d. terrificus’ venom proteome is composed of 12 protein families, which are unevenly distributed in the venom, e.g., there are few major proteins in the 
venom’s composition phospholipase A2, serine proteinase, crotamine and L-amino acid oxidase. At the same time, the proteome analysis revealed a small set of 
proteins with low quantity (less than 1.5%), both enzymes (metaloprotease, phospholipase B and 50-nucleotidase) and proteins (Bradykinin potentiating and C-type 
natriuretic peptides, C-type lectin convulxin and nerve growth factor). To sum up, this research is the first venomic report of C.d.terrificus venom from Argentina. This 
proved to be crotamine positive venom that has a lower metalloprotease content than C.d. terrificus venoms from other regions. This information could be used in the 
discovery of future pharmacological agents or targets in antivenom therapy.   
1. Introduction 
Accidents with Crotalus durissus terrificus (C.d. terrificus) are an 
important public health issue in South America (Calvete et al., 2010). In 
Argentina, envenomation caused by this species is of medical impor-
tance due to the lethality of their venom (Garcia Denegri et al., 2019). 
Such cases are often fatal, when treatment with specific antivenom is not 
quickly administered (Acosta de Perez et al., 1997; Baudou et al., 2017; 
de Roodt et al., 1998). 
Neurotoxic paralysis is the major clinical effect in envenomation by 
C.d.terrificus, whereas local effects are small or even absent (Rosenfeld, 
1971). The envenomation causes neurotoxic, myotoxic, and coagulo-
pathic effects (Acosta de Perez et al., 1997). Regarding systemic myo-
toxicity, it could lead to acute renal failure, also with tubular necrosis 
(Amaral et al., 1980; Azevedo-Marques et al., 1985). 
In general terms, the venomic of C.d.terrificus comprises toxins from 
different protein families: phospholipases A2, serine proteinases, 
50nucleotidases, metalloproteinases, nerve growth factors, phosphodi-
esterases, glutaminylcyclase, C-type lectin, crotamine, L-amino acid 
oxidase and disintegrins (Boldrini-França et al., 2010; Georgieva et al., 
2010; Gutierrez et al., 2009; Wiezel et al., 2018). Additionally, using 
different bottom-up approaches, Melani and collaborators (2015) pro-
vided more information about the proteomic characterization of this 
venom. They also describe the presence of CRISP, phospholipase-B, 
snake venom vascular endothelial growth factor (svVEGF) and other 
proteins involved in the regulation of toxin synthesis and processing 
(Melani et al., 2015). 
Venomic analysis is a tool to evaluate new sources of biologically 
compounds of therapeutic value (Radha and Kumaran, 2018). It is also 
important for better understanding the ecological and evolutionary re-
lationships among snake species, and for the preparation of more 
effective toxin-specific antivenoms. Regarding evolution, some authors 
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show the distributional history of the neotropical rattlesnake in South 
America and the Amazon. The phylogeographic pattern of C.durissus sp. 
is best explained by a Pleistocene trans-Amazonian corridor of contin-
uous distribution: past savanna or dry forest vegetation Adrian 
Quijada-Mascare~nas et al., 2007). C. d .terrificus is a subspecies that it is 
found only in South America and its geographical distribution is shown 
in Fig. 1 (http://www.reptile-database.org/). 
C.d. terrificus whole venom as well as some isolated toxins (PLA2, 
SVSP) from specimens that inhabit in Argentina, were further studied 
with respect to the toxicological properties (Acosta de Perez et al., 1997; 
Fusco et al., 2015a, 2015b; Marunak et al., 2004; Rodríguez et al., 2006, 
2009, 2012; Ruiz de Torrent et al., 2007), but no previous proteomic 
reports have been found. Knowledge about the toxins from venoms is the 
basis for the treatment of victims, and the selection of specimens for the 
preparation of venom pools for antivenom production (Gutierrez et al., 
2009). Here we used a fast and direct venomics approach (Calvete et al., 
2007, 2009; Gutierrez et al., 2009) to identify the toxin families in the C. 
d. terrificus rattlesnake. 
2. Material and methods 
2.1. Venom 
Crotalus d. terrificus venom was pooled from 25 specimens of adult 
snakes held in the serpentarium of the local Zoo (CEPSAN), Corrientes, 
Argentina. The venom was lyophilized and kept frozen at   20 �C. 
2.2. Reverse phase (RP) HPLC 
Five mg of C.d. terrificus venom were dissolved in 200 mL of solvent A 
Fig. 1. C.d. terrificus distribution in South America (green area), reptile area follows the electronic database accessible at http://www.reptile-database.org accessed 
on 14 May 2020. Symbols indicate the approximate regions of origin of the snakes sampled in previous and present work: ■;-Wiezel et al. (2018),�- Melani et al. 
(2015), ▴- Boldrini-França et al. (2010), O – Georgieva et al. (2010), Ф Present work. 
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(0.1% (v/v) trifluoroacetic acid; TFA). The resulting solution was clar-
ified by centrifugation at 5000�g for 5 min and the supernatant was 
applied to a Discovery C18 column (4.6 mm � 25 cm; Akta Purifier 
system). Proteins were eluted with a gradient (0–20%, 20–60%, 
60–100%) of 66% (v/v) acetonitrile in solvent B, at a flow rate of 1 mL/ 
min. The elution profile was monitored at 215 nm and the fractions were 
collected, dried in speed vac and stored at   20 �C. Values of area under 
the curve were used to estimate the relative abundance of each protein 
family (%). 
2.2.1. Protein mass determination by mass spectrometry 
The dried samples from RP-HPLC fractions were re-dissolved (in 
0.1% acetic acid) and analyzed using a matrix-assisted laser desorption 
ionization-time of flight (MALDI-TOF) mass spectrometer (Axima Per-
formance, Shimadzu). One microliter of each sample was co-crystallized 
with 1 μL of sinapic acid matrix (saturated solution prepared in 50% 
ACN/0.1% acetic acid) in the plate and dried at room temperature. The 
mass spectrum was obtained in the 50–50,000 mass/charge (m/z) range, 
in linear positive mode. 
2.2.2. Protein identification by proteomic analysis 
The samples from RP-HPLC fractions were buffered in ammonium 
bicarbonate 50 mM, pH7), and then dithiothreitol (10 mM final con-
centration) was added and left for 1 h at 60 �C; after that, iodoacetamide 
(IAA) (10 mM final concentration) was added and incubated for 1 h, at 
room temperature and protected from light. Next, 10 μL of trypsin (40 
ng μL  1 in 100 mMTris-HCl, pH 8.5) was added. The incubation was 
performed overnight, at room temperature. The reaction was stopped by 
adding 50% ACN/5% TFA. 
The samples were then analyzed by liquid chromatography-mass 
spectrometry using an ESI-IT-TOF (LCMS-IT-TOF/Shimadzu Co., 
Kyoto, Japan) system coupled to a binary ultra-fast liquid chromatog-
raphy system (UFLC) (20A Prominence, Shimadzu). Each sample was 
loaded in a C18 column (Discovery C18, 5 μm; 50 � 2.1 mm) in a binary 
solvent system: (A) water: acetic acid (999:1, v:v) and (B) ACN: water: 
acetic acid (900:99:1, v:v:v). The column was eluted at a constant flow 
rate of 0.2 mL min  1 with a 0–40% gradient of Solvent B over 35 min. 
The eluates were monitored by a Shimadzu SPD-M20A PDA detector 
before checking on the mass spectrometer. The interface voltage was 4.5 
kV; the capillary voltage was 1.85 kV, at 200 �C; and the fragmentation 
was induced by argon collision, at 55% ‘energy’. MS spectra were ac-
quired under positive mode and collected in the 350–1400 mass/charge 
(m/z) range. MS/MS spectra were collected in the 50–1950 m/z range. 
LCD Shimadzu raw data were converted (LCMS Protein Postrun, 
Shimadzu) to Mascot Generic Format (MGF) files prior to analyses. 
Peaks Studio V7.0 (BSI, Toronto, ON, Canada) was used for data pro-
cessing (de novo peptide sequencing and proteomic identification) (Ma 
et al., 2003). Peaks Studio V7.0 (BSI, Toronto, ON, Canada) was used for 
data processing (Ma et al., 2003). Proteomic identification was per-
formed according to the following parameters: error mass (MS and 
MS/MS) set to 0.2 Da; methionine oxidation and carbamidomethylation 
as variable and fixed modification, respectively; trypsin method; 
maximum missed cleavages (3), maximum variable Post-Translational 
Modifications (PTMs) per peptide (3) and non-specific cleavage (one). 
The samples were analyzed against a provide specific information on 
UniProt database (UniProtKB/Swiss-Prot, 2020- Total entries 562,253). 
2.3. Proteolytic activity 
Caseinolytic activity was measured colorimetrically by a modified 
procedure described (Kreger and Lockwood, 1981) with slight modifi-
cations. The reaction mixture, consisting of 142 μL azocasein (5 mg/mL) 
in PBS (phosphate-buffered saline, pH 7.2), 25 μL venom dilution (5, 2.5, 
1.25, 0.6 mg/mL) in PBS buffer, was incubated for 90 min at 37 �C. The 
reaction was quenched by the addition of 334 μl of 5% trichloroacetic 
acid and rest for 30 min at room temperature. After centrifugation at 
13000�g for 5 min, 100 μL of the supernatant was mixed with the equal 
volume of 0.5 M NaOH and absorbance was measured at 450 nm and the 
percentage of activity was calculated. B. alternatus venom was used as 
positive control (100% of caseinolytic activity). Assays were run in 
triplicate including appropriate blanks. 
3. Results and discussion 
The combination of RP-HPLC and mass spectrometric analyses was 
used to identify the major protein components from the crude venom 
that comes from specimens that inhabit the Northeast region of 
Argentina. The RP-HPLC separation profile of pooled venom from adult 
specimens (Fig. 2), followed by mass spectrometry analysis (Supple-
mentary Table 1 and Fig. 1), revealed that C.d. terrificus venom proteome 
is made up of 12 protein families, which are unevenly distributed in the 
venom, e.g., there are few major proteins in the venom composition 
(Table 1). 
Our protocol, however, differs from others previously described 
(Calvete, 2011; Calvete et al., 2007, 2009; Gutierrez et al., 2009). The 
first step was the separation of one (or several) protein components from 
the whole venom by reversed-phase chromatography. This was carried 
out to increase the detection sensitivity for minor components of the 
protein mixture in the subsequent identification steps. In sequence the 
mass and complexity of the protein samples were analyzed by 
MALDI-TOF, and the proteins were identified by ESI-IT-TOF and pro-
teomic analysis. 
The venom of C.d.terrificus from Brazil has been extensively studied 
by proteomic methods. In this sense, at least five proteomic studies were 
found (Boldrini-França et al., 2010; Calvete et al., 2010; Georgieva et al., 
2010; Melani et al., 2015; Wiezel et al., 2018) four of them as listed in 
Table 2. The first proteomic C.d. terrificus study was performed by Cal-
vete et al. (2009), but the geographical origin of the venom is unknown 
because the venom was purchased from Latoxan (Valence, France). 
Later, other studies (Table 2) were performed, and increased informa-
tion on the composition of venom components, and their relations with 
geographic and ontogenetic changes of specimens belonging to this 
subspecies (Fig. 1). In this sense, variations in the relative quantity of 
CTX were determined in venoms from different geographic regions and, 
in general, exceeded 50% of the total venom protein composition. Serine 
(SVSP) and metaloprotease (SVMP) families were present in all venoms 
analyzed. Other components were also present in small percentages 
(�3%). 
In this work, the C.d. terrificus from Argentina venom proteins were 
analyzed, and our results showed similar composition to other rattle-
snake venoms from Brazilian snakes. However, as discussed below, some 
differences were detected. 
Crotoxin is abundant in the venom of C.d. terrificus (60.7%), and this 
figure is close to information from Melani and collaborators (2015). As 
we have previously reported (Fusco et al., 2015a, 2015b), PLA2 from 
crotoxin complex (crotoxin basic chain, CTX B-chain) is present in 
different molecular forms in the venom. This enzyme could be detected 
in fractions 13 and 15 to 21 in the RP-HPLC separation (Fig. 2) and 
accounted for 30.7% of total venom proteins (Table 1). The molecular 
masses vary between 13.551,1 and 14.259,7 Da. With a similar abun-
dance (30.0%), crotoxin acid chain (CTX A-chain) was detected in 
fractions 7 to 12 and their molecular masses were around 10 kDa. Hence, 
we were able to detect eight molecular forms of CTX B-chain and six of 
CTX A-chain. This is in agreement to previous studies reported by other 
authors, who informed that crotoxin is a mixture of variant forms of each 
component (Faure et al., 1993, 1994). 
Serine proteinases constitute another large protein family of the C. d. 
terrificus venom. They were present in about 1–25% in all C.d. terrificus 
venom studied (Table 2). The quantity observed was intermediate 
(18.3%) in the venom here studied. In RP-HPLC profile the SVSP was 
detected in a fraction 14 closed to CTX B-chain fractions and in a non- 
resolved fraction (19–23). This proteinases group featured a molecular 
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mass around 29 kDa, similar to what was reported by Calvete et al. 
(2009). Some SVMPs detected by MS/MS analysis belonging to the 
fibrinogenases subgroup (peak 21, Supplementary Data Table 1). All this 
evidence agrees with Maru~nak and collaborators works, who isolated a 
33 kDa (by SDS-PAGE) SVMP from C.d. terrificus venom of Argentina. 
The isolated enzyme exhibited a thrombin-like activity and strong hy-
drolyzing activity on fibrinogen and fibrin (Marunak et al., 2004). These 
venom serine proteinases may be part of a family with multiple mo-
lecular forms (Yonamine et al., 2009). 
Regarding the metalloproteinases, rattlesnake venom from Brazilian 
specimens present SVMPs in low relative quantities (Calvete et al., 
2010). The mass spectrometry analysis of RP-HPLC fractions of pooled 
venom from adult C.d. terrificus specimens from Argentina (Fig. 2), 
revealed the presence of one peptide belonging to the catalytic domain 
of SVMP (Supplementary Data, Table 1). This evidence was found in 
fraction 25, a pool of several proteins (LAOO, SVSP, 50ND, PLB) all in 
Fig. 2. Characterization of the venom proteome of C.d. terrificus from Argentina. Reverse-phase HPLC separations of the proteins from venom of specimens of 
Crotalus (lower in the panel). Protein Mass Determination by mass spectrometry (upper in the panel). 
Table 1 
Assignment of the proteins isolated by reversed-phase HPLC of the Crotalus 




Protein Family %  
13,15-19 Crotoxin basic chain 30.7 CTX B- 
chain 
7–12 Crotoxin acid chain 30.0 CTX A- 
chain 
14,19-23 Serine Proteinase 18.3 SVSP 
2–3 Crotamine 7.7 CTM 
24–26 L-amino-acid oxidase ̴ 3.0 LAAO 
26 Phosphodiesterase ̴ 2.6 PDE 
18 Vascular endothelial growth factor <1.5 svVEGF 
4,5,6,25 Zinc metalloproteinase-disintegrin <1.4 SVMP 
1 Bradykinin potentiating and C-type natriuretic 
peptides 
<1.2 BBP/C-NP 
27 C-type lectin convulxin <1 CTL 
28 Snake venom 50-nucleotidase <0.2 50NT 
28 Phospholipase B <0.2 PLB 
28 Venom nerve growth factor <0.2 VNGF  
Unidentified 2.2 NI  
Table 2 
Overview of the relative occurrence and comparison with previously studies of 
protein families identified of Crotalus durissus terrificus venom.  
Protein Family Present Work 1 2 3 4 
CTX A/B-chain 60.7 59.5 48.5 69.3 89.4 
SVSP 18.3 8.2 25.3 13.4 1.43 
CTM 7.7 19.0 ND 1 ND 
LAAO ̴ 3.0 4.5 ND 3 ND 
PDE ̴ 2.6 ND 1.9 1.2 0.39 
svVEGF <1.5 ND ND ND 2.2 
SVMP <1.4 4.8 3.9 2.9 6 
BBP/C-NP <1.2 2.8 ND 0.2 0.04 
CTL <1 1.7 ND 2.7 0.02 
50-NT <0.2 ND 7.8 0.4 0.39 
PLB <0.2 ND ND 0.2 0.04 
VNGF <0.2 ND 1.9 0.4 0.15 
Non identify 2.2 ND 9.7 ND ND 
Glutaminyl cyclase ND ND 1 N ND 
CRISP ND ND ND 0.2 ND 
Hyaluronidase ND ND ND 0.8 0.45 
1.(Calvete et al., 2010); The origin of the venom was not determined (ND). 
2.(Georgieva et al., 2010); San Maru Serpentarium, Taquaral, S~ao Paulo. 
3.(Melani et al., 2015); Butantan Institute, S~ao Paulo. 
4.(Wiezel et al., 2018); Ribeiraeo Preto, S~ao Paulo. 
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very low quantity. The 25 peak area from RP-HPLC profile represents 
minor of 2% of total chromatogram area. In agreement with this 
observation, C.d.terrificus venom exhibited a low proteolytic activity. 
Only the highest concentrations tested (2.5–5 mg venom/mL) were 
capable of hydrolyze casein, and the activity was 5% of that for 
B. alternatus venom (a well-known venom by its high proteolytic activ-
ity) under similar conditions. The activity was not detected at lower 
venom concentrations assayed. In light of these results, it can be inferred 
that C.d. terrificus venom has SVMP only as traces. This confirms ob-
servations that have been reported in previous works. At the same time, 
the very low level of SVMP detected may explain the lack of hemor-
rhagic activity, as it was described for this venom. (Acosta de Perez 
et al., 1997; Garcia Denegri et al., 2019). 
Disintegrins are a family of polypeptides present in the venoms of 
Viperidae and Crotalidae snakes (vipers and rattlesnakes) (Calvete, 
2013). In the present work, zinc metalloproteinase/disintegrins were 
detected at the beginning of the chromatogram in fraction 5 (Fig. 2). Our 
results are agreement to Wiezel and collaborators who detected two 
disintegrins isoforms in C.d. terrificus venom from Brazilian specimens 
(Table 2), while Calvete et al., 2010, Georgieva et al., 2010 and Melani 
et al., 2015, did not find these proteins in the venoms analyzed. Dis-
integrins detected in this work showed molecular masses around 7.4 kDa 
and this value similar to disintegrins isolated from venoms of Crotalus 
durissus subspecies as C.d.collilineatus and C.d.cascavella (Boldrini--
França et al., 2010), as well as other Crotalus species and subspecies, 
such as those studied by Scarborough et al. (1993), C. atrox and C.d. 
durissus. Additionally, S�anchez et al. (2006) also reported the charac-
terization of mojastin 1 (7.436 kDa) and 2 (7.636 kDa) with masses 
around 7.5 kDa present in the venom of C.s. scutulatus (S�anchez et al., 
2006). These reports of the presence of disintegrins are from venoms 
containing SVMPs. The presence of disintegrins could be due to the 
direct synthesis from short-coding mRNAs (Calvete, 2010). 
On the other hand, a peptide belonging to the prodomain of SVMP 
was identified by MS/MS analysis of fraction 3 (Supplementary Data 
Table 1). Simultaneously the MALDI-TOF analyses of this fraction 
showed the presence of proteins with molecular mass around 5 kDa. 
Although SVMP prodomain peptides are very rare in vipers venome, 
they have been described in some venoms (Moura-da-Silva et al., 2016). 
Taken together, these results could be indicating that the SVMP 
molecule “pool” in the C.d. terificus venom is a mixture of fully- and 
partially processed (active) metalloproteinases, as well as well as un-
processed zymogens, as described Nicolau and cowokers in Bothrops 
jararaca venom proteopeptidomic analysis (Nicolau et al., 2017). In 
Table 2 the percentual content of this proteins family is shown. This 
value (<1.4%) is lesser between the obtained values for all C.d. terrificus 
venom studied. 
Crotamine represents approximately 8% of the protein composition 
of the total venom. Here, it was detected in fractions 2 and 3, i.e., var-
iants forms showing molecular masses close to 5 kDa. It is well known 
that Crotamine is a small basic myotoxin (Falcao and Radis-Baptista, 
2019; R�adis-Baptista and Kerkis, 2011). Johara Boldrini-França et al. 
(2010) reported the increased frequency of crotamine-positive pop-
ulations from Southeast to Southern Brazil for C.d. terrificus. In this 
sense, some authors describe crotalid venoms as crotamine-positive or 
–negative specimens and correlating with different toxicological prop-
erties (Cameron and Tu, 1978; Schenberg, 1959). The C.d. terrificus 
venom from Argentina is crotamine positive as was demonstrated not 
only in the identification proteomic analysis, but was also previously 
reported by Echeverría et al. (2016). 
Studies from other South American rattlesnakes have pointed 
increased neurotoxicity southwards along the North-South axis of the 
species dispersal into South America (Boldrini-França et al., 2010; Cal-
vete et al., 2010). Our results indicate that C.d.terrificus venom has a 
high content of neurotoxins (crotoxin and crotamin). This finding are in 
concordance with those reported by Calvete and collaborator (2010) 
who showed the gain of neurotoxicity and lethal venom activities to 
mammals venom toxicity has evolved during Crotalus durissus invasion 
of South America. This analysis was supported by mapping a “lethal 
neurotoxicity coefficient” (LNC), which these authors define as the ratio 
between the average LD50 (μg/kg) of the venom and the crotoxin þ
crotamine concentration (Supplementary Table 2).The overall analysis 
of venom composition, LD50 and LNC of C. d. cascavella, collilineatus and 
terrificus subspecies venoms closely resemble that of C. d. terrificus 
venom from Argentina, supporting the hypothesis that these taxa can be 
considered geographical variations of the same species (Boldrini-França 
et al., 2010). 
L-amino acid oxidase and PDE are usually minor components in the 
mixture of protein and represent between 1.2 and 3% (Table 2) of the 
venom composition. 
LAAO was detected at the beginning of RP-chromatography (frac-
tion1), as well as at the end (fractions 24–26) co-eluting with minor 
protein components, as CTL (<1%), 50NT (<0.2%), PLB (<0.2%) or 
VNGF (<0.2%). In comparison with studies from other authors, this 
protein was not always detected. In this present work, LAAO represents 
around three percent of the whole venom. Since it is a large protein, this 
atypical chromatographic behavior could be due to isoforms or to pro-
tein cleavage (either artifactual or already present in the venom). 
Bordonein-L, the L-amino acid oxidase from C.d. terrificus, has been 
previously studied and characterized (Bordon et al., 2015; Wiezel et al., 
2019). 
Phosphodiesterases (PDE) are one of the lesser abundant enzymes in 
snake venoms, they hydrolyze phosphodiester bonds from the 3’ ter-
minus of polynucleotides producing 5-mononucleotides (Fox, 2013). 
Although PDEs account for only around 2 percent of total venom pro-
teins, it was postulated that this enzyme would induce important clinical 
disorders during the intoxication process (Mackessy, 2016). In this 
work, PDE was detected in fraction 26 and represents circa 2.6 percent 
of the venom proteins. In a previous study, we have identified two PDEs 
from C.d. terrificus from Argentina, with molecular mass of ~ 100 kDa 
(Fusco et al., 2016). Our findings are in accordance with Georgieva and 
collaborators which identified 2 phosphodiesterase spots thorough 
proteomic research of the 2D-separated venom (Georgieva et al., 2010). 
The proteome analysis revealed a small set of proteins with a low 
quantity (less than 1.5%), both enzymes (PLB, 50NT) and proteins (BBPs, 
CTL and svVEGF). Their presence in this venom is discussed below. 
The first RP-HPLC fraction contained bradykinin potentiating pep-
tides (BBPs). BBPs are prolinerich peptides which structural de-
terminants were recently reviewed by Sciani and Pimenta (2017). BBPs 
have already been isolated from Crotalus genera (Gomes et al., 2007; 
Lopes et al., 2014). From C.d. terrificus two homologous cDNAs encoding 
the BPPs precursor protein were cloned (Gomes et al., 2007). These 
peptides, together with crotamine, represent the two families of C.d. 
terrificus venom small molecules (Wermelinger et al., 2005). 
The glycosylated C-type lectin from venom of C.d. terrificus (CVX) 
(Murakami et al., 2003) could be identified by reverse-phase separation 
as the C-type lectinconvulxin, and it was one of the most hydrophobic 
proteins fractionated. Similar observations were made by other authors 
when studying the venom of Brazilian snakes (Boldrini-França et al., 
2010; Calvete et al., 2010; Melani et al., 2015; Wiezel et al., 2018). 
In the present work 50 nucleotidase, phospholipase B and venom 
nerve growth factor were detected as the most hydrophobic proteins 
from the C.d. terrificus venom (fraction 28) and co-eluted together at the 
end of RP-HPLC profile. These proteins represent less than 0.2 percent of 
the proteome. 
As it was mentioned, toxicological properties of C.d. terrificus venom 
from Argentina as well as of isolated toxins were further studied. The 
venomic results here obtained are largely agreeing with previous 
biochemical venom characterization, and they provide novel informa-
tion about the presence of proteins (e.g. desintegrins) that, even in low 
levels, are interesting to isolate and study them. 
In conclusion, this proteomic analysis allowed us to identify proteins 
from C.d. terrificus venom from adult snakes that inhabit the north 
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region of Argentina, as well as the comparison to the previously data 
obtained by authors who studied crotalic venom from Brazil. The results 
reveal that, despite the geographical proximity, the venom from C.d. 
terrificus presents many similarities and some differences to the Brazilian 
snake venom. The proteome here described shows, in general, the 
typical and expected protein composition for C.d. terrificus venom. 
Nevertheless, this crotamine positive venom has a lower metal-
loprotease content than C.d. terrificus venoms from other regions. This 
information is relevant for the design of pan-south American C.d.terri-
ficus antivenom. 
Declaration of competing interest 
The authors declare that they have no known competing financial 
interests or personal relationships that could have appeared to influence 
the work reported in this paper. 
CRediT authorship contribution statement 
Luciano S. Fusco: Conceptualization, Investigation, Writing - orig-
inal draft. Emidio B. Neto: Formal analysis, Methodology, Software. 
Aleff F. Francisco: Resources, Validation. Jorge Alfonso: Resources. 
Andreimar Soares: Funding acquisition, Supervision. Daniel C. 
Pimenta: Funding acquisition, Project administration, Writing - original 
draft. Laura C. Leiva: Writing - review & editing, Project 
administration. 
Acknowledgment 
We thank to Laura Rey from CEPSAN, for her technical assistance 
and venom provision. 
This work was supported by Coordenaç~ao de Aperfeiçoamento de 
Pessoal de Nível Superior [grant #001 to EBN], Financiadora de Estudos 
e Projetos [grants #01.09.0278.04 and #01.12.0450.03], Conselho 
Nacional de Desenvolvimento Científico e Tecnol�ogico (CNPq) 
[406385/2018-1 to DCP] DCP, is a CNPq fellow researcher [grant 
#303792/2016-7]. This research was financialy supported by Fondo 
para la Investigaci�on Científica y Tecnol�ogica (FONCyT). PICT-JOVEN 
038. The authors express their gratitude to Consejo Nacional de Inves-
tigaciones Científicas y T�ecnicas (CONICET) and Universidad Nacional 
Del Nordeste de Argentina for the support of their researchers, to Sec-
retaria General de Ciencia y Tecnica de la UNNE for financing to Dr 
Fusco their travel to Brazilian laboratories, to Conselho Nacional de 
Desenvolvimento Científico e Tecnol�ogico (CNPq), to Coordenaç~ao de 
Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Fundaç~ao de 
Amparo �a Pesquisa do Estado de Rondônia (FAPERO) from Brasil, as 
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